Marshall Wace’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-44,809
Closed -$2.29M – 3195
2024
Q4
$2.29M Buy
44,809
+3,450
+8% +$170K ﹤0.01% 1381
2024
Q3
$1.71M Sell
41,359
-243,250
-85% -$11.7M ﹤0.01% 1431
2024
Q2
$13.7M Sell
284,609
-434,290
-60% -$19.2M 0.02% 611
2024
Q1
$34.5M Buy
718,899
+368,171
+105% +$19.7M 0.05% 341
2023
Q4
$22.8M Sell
350,728
-113,179
-24% -$6.81M 0.04% 440
2023
Q3
$30.3M Buy
463,907
+200,331
+76% +$12.6M 0.06% 317
2023
Q2
$15.3M Sell
263,576
-131,857
-33% -$8.32M 0.03% 580
2023
Q1
$24.4M Buy
+395,433
New +$23.7M 0.05% 398
2021
Q1
– Sell
-19,150
Closed -$1.67M – 2939
2020
Q4
$1.67M Buy
+19,150
New +$1.35M 0.01% 1022

Other funds holding NARI

Marshall Wace's NARI Position: Q1 2025 in Review

Marshall Wace sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 44,809 shares — an estimated $2.29M sold.

Marshall Wace first reported a position in NARI in Q4 2020 and held it in 9 quarters. The position peaked at $34.5M in Q1 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Marshall Wace reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Marshall Wace sold 44,809 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $2.29M.
  • Marshall Wace first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • Marshall Wace's Inari Medical, Inc. Common Stock position peaked at $34.5M in Q1 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Marshall Wace's 13F filing for Q1 2025, filed 15 May 2025.